NCT02851602View on ClinicalTrials.gov

Phospholipid and Sphingolipid Composition of High-density Lipoproteins (HDL) in Obese Non-diabetic Patients With Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

November 18, 2013

Primary Completion Date

November 14, 2016

Study Completion Date

November 14, 2016

Conditions
Metabolic Syndrome
Interventions
BIOLOGICAL

Blood sample

Trial Locations (1)

21079

CHU Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02851602 - Phospholipid and Sphingolipid Composition of High-density Lipoproteins (HDL) in Obese Non-diabetic Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter